1993
DOI: 10.1055/s-2007-1010315
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic and Bioptic Findings in the Upper Gastrointestinal Tract in Patients with Crohn's Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
41
0
2

Year Published

1998
1998
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(45 citation statements)
references
References 0 publications
2
41
0
2
Order By: Relevance
“…However, the positivity rate is low. 19,20 Few reports have examined the relationship between H. pylori infection of the stomach and gastric Crohn's disease, but the rate of H. pylori infection in patients with idiopathic inflammatory bowel disease (IBD) seems to be low, 21,22 and this appears to be related to treatment with SASP. 23 In our patient, tests for H. pylori were negative.…”
Section: Discussionmentioning
confidence: 99%
“…However, the positivity rate is low. 19,20 Few reports have examined the relationship between H. pylori infection of the stomach and gastric Crohn's disease, but the rate of H. pylori infection in patients with idiopathic inflammatory bowel disease (IBD) seems to be low, 21,22 and this appears to be related to treatment with SASP. 23 In our patient, tests for H. pylori were negative.…”
Section: Discussionmentioning
confidence: 99%
“…8 In this context, radiology, serologic testing (ASCA; anti-Saccharaomyces cerevisiae and ANCA; anti-neutrophil cytoplasmic antibody), and upper endoscopy combined with random biopsies for evaluating granuloma are recommended. 9 Although endoscopic ultrasonography had been initially recognized to be effective in differentiating between CD and UC, it is now considered to have a limited function in this setting. 10 Novel diagnostic tools as wells as conventional endoscopy are needed to positively identify this group.…”
Section: Diagnosismentioning
confidence: 99%
“…Endoscopic and histologic involvement might be found in up to 40% of patients [84][85][86] . Due to the low frequency of patients with symptomatic gastroduodenal involvement, however, randomized, placebo-controlled trials are not available.…”
Section: Gastroduodenal CDmentioning
confidence: 99%